Tempus ai stock forecast analysts tracking Tempus AI stock

Analysts tracking Tempus AI stock forecast emphasize growing deal flow with hospital networks, which could add $150M+ in recurring annual revenue, strengthening its SaaS-based predictive analytics leadership. Tempus AI shares only began being traded publicly last June, and despite today's drop they're still about 45% above their initial price. Marvell Is Down 47% From All-Time Highs. Is MRVL Stock Undervalued or a Value Trap? Momentum indicators in Tempus AI stock forecast suggest RSI levels approaching 65, which traders interpret as strong buying interest without yet being overbought, giving room for upward price movement.